Skip to main content
. Author manuscript; available in PMC: 2016 Mar 15.
Published in final edited form as: Int J Cancer. 2014 Aug 7;136(6):1254–1262. doi: 10.1002/ijc.29102

Figure 1.

Figure 1

Experimental scheme for treatment of pregnant gpt delta C57BL/6J mice at gestation day 14 (GD14) with 6 mg/kg of AFB1, analysis of AFB1-DNA adducts at 6 hr and analysis of mutations in the gpt transgene at postnatal day 21 (3 weeks) and 70 (10 weeks) after birth.